Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMortgage Advice Bureau Regulatory News (MAB1)

Share Price Information for Mortgage Advice Bureau (MAB1)

Share Price is delayed by 15 minutes
Get Live Data
535.00    10.00 (1.90%)
Bid:
532.00
Ask:
535.00
Spread: 3.00 (0.564%)
Market Cap: £307.86m
MAB1 Live PriceLast checked at - London Stock Exchange

Intraday Mortgage Advice Bureau Share Chart

Pre-close Trading Update

25 Jul 2017 07:00

RNS Number : 9489L
Mortgage Advice Bureau(Holdings)PLC
25 July 2017
 

25 July 2017

Mortgage Advice Bureau (Holdings) plc ("MAB" or the "Group")

Pre-close Trading Update 

This announcement contains inside information.

Mortgage Advice Bureau (Holdings) plc (AIM: MAB1), one of the UK's leading consumer intermediary brands and specialist Appointed Representative Networks, today issues a pre-close trading update for the six months ended 30 June 2017, ahead of publishing its interim results announcement on Tuesday, 26 September 2017(1).

Revenue for the six months ended 30 June 2017 increased by 15% to £49 million driven by a 14% increase in the average number of Advisers to 974 over the period(2). The total number of Advisers had increased to 1,008 at 30 June 2017, an increase of 58 or 6% since last year end (950 at 31 December 2016). As previously reported on 24 May 2017, organic recruitment has been in line with the Board's expectations and we expect new business recruitment to be weighted to the second half of the year. At 30 June 2017, the Group had a strong balance sheet with a cash position of £19 million, including £11 million of unrestricted cash balances. 

In H1 2016 average revenue per Adviser increased by 9% compared to H1 2015 due to the spike in Buy-To-Let applications resulting from the impending stamp duty changes in April 2016. Against this backdrop we have seen modest growth in productivity in the six months ended 30 June 2017 and we expect this to continue. Current trading is in line with the Board's expectations and the Board looks forward to delivering further growth in the remainder of this financial year.

(1) The interim dividend in respect of the six months ended 30 June 2017 will be paid on 27 October 2017 and the record date is 6 October 2017.

(2) The average number of Advisers in the twelve months ended 30 June 2017 was 950 (2016: 811).

Peter Brodnicki, CEO of Mortgage Advice Bureau (Holdings) plc, said:

"Activity overall in the housing market has remained steady and was not unduly affected by the election in early June. There are some signs of softening home mover activity. However, for most of those moving home currently, it is not a discretionary decision, with lifestyle factors causing them to need to move. The remortgaging market both for residential and buy-to-let remains steady.

"We continue to enjoy a strong financial position and are focussed on our market share growth. Our technology developments are progressing well and will help drive our future market share growth and further strengthen MAB's overall market position in 2018 and beyond."

 

Enquiries:

Mortgage Advice Bureau (Holdings) plc +44 (0)1332 525007

Peter Brodnicki, Chief Executive Officer

David Preece, Chief Operating Officer

Lucy Tilley, Finance Director

Nominated Adviser and Joint Broker:

Zeus Capital +44 (0)20 3829 5000

Martin Green

Nicholas How

Pippa Underwood

 

Joint Broker:

Canaccord Genuity +44 (0)20 7523 8350

Andrew Buchanan

Richard Andrews

 

Media Enquiries: 

investorrelations@mab.org.uk

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTSELFWLFWSEDW
Date   Source Headline
1st Dec 20255:25 pmRNSDirectors' Shareholdings and PDMR notification
18th Nov 20252:11 pmRNSDirectors' Shareholdings and PDMR notification
14th Nov 20257:00 amRNSNotice of Capital Markets Day Update
7th Nov 20255:15 pmRNSHolding(s) in Company
4th Nov 20251:34 pmRNSDirector/PDMR Shareholding
16th Oct 202512:40 pmRNSDirector/PDMR Shareholding
16th Oct 202512:38 pmRNSGrant of Options, PDMR Dealing,Total Voting Rights
30th Sep 20254:43 pmRNSDirector/PDMR Shareholding
25th Sep 20254:30 pmRNSDirector/PDMR Shareholding
23rd Sep 20255:01 pmRNSBlock listing Interim Review
23rd Sep 20257:00 amRNSInterim Results
17th Sep 20252:30 pmRNSDirector/PDMR Shareholding
2nd Sep 20257:00 amRNS-RNotice of HY25 Results and Investor Presentation
29th Aug 20251:13 pmRNSDirector/PDMR Shareholding
27th Aug 20254:26 pmRNSHolding(s) in Company
21st Aug 20253:01 pmRNSDirector/PDMR Shareholding
31st Jul 202511:32 amRNSDirector/PDMR Shareholding
24th Jul 20257:00 amRNSTrading Update
22nd Jul 20255:59 pmRNSEBT Share Purchase
17th Jul 20259:46 amRNSDirector/PDMR Shareholding
16th Jul 20251:58 pmRNSHolding(s) in Company
9th Jul 20259:05 amRNS-RMAB Launches First-Time Buyer Campaign
3rd Jul 20259:54 amRNSDirector/PDMR Shareholding
27th Jun 20253:46 pmRNSNotification of major holdings
19th Jun 20257:00 amRNSBoard Changes
18th Jun 202510:55 amRNSDirector/PDMR Shareholding
11th Jun 202510:18 amRNSHolding(s) in Company
3rd Jun 20252:47 pmRNSDirector/PDMR Shareholding
30th May 20253:52 pmRNSDirector/PDMR Shareholding
22nd May 20257:00 amRNSResults of Annual General Meeting
21st May 20257:00 amRNSAGM Trading Statement
16th May 202512:30 pmRNSDirector/PDMR Shareholding
6th May 202512:37 pmRNSHolding(s) in Company
1st May 20255:19 pmRNSDirectors' Shareholdings and PDMR notification
30th Apr 20255:15 pmRNSGrant of Options, PDMR Dealing and TVR
29th Apr 20258:48 amRNSNotice of AGM
17th Apr 20251:40 pmRNSHolding(s) in Company
16th Apr 20259:58 amRNSDirector/PDMR Shareholding
10th Apr 20257:00 amRNSAppointment of Joint Corporate Broker
4th Apr 20257:10 amRNSAnnual Report and Notice of AGM
1st Apr 20253:51 pmRNSDirector/PDMR Shareholding
27th Mar 20259:18 amRNSHolding(s) in Company
19th Mar 20257:00 amRNSDirectorate Change
18th Mar 20257:00 amRNSFinal Results for the year ended 31 December 2024
17th Mar 20253:40 pmRNSDirector/PDMR Shareholding
14th Mar 20257:00 amRNSBlock Admission Application
5th Mar 202511:29 amRNSDirector/PDMR Shareholding
26th Feb 20257:00 amRNS-RNotice of Investor Presentation
18th Feb 20253:57 pmRNSDirector/PDMR Shareholding
17th Feb 20253:29 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.